Clinical trial · Interventional
Conventional or Unconventional Lymph Node Dissection During Resection of Intrahepatic Cholangiocarcinoma
A Randomized Controlled Study of Conventional or Unconventional Lymph Node Dissection During Resection of Intrahepatic Cholangiocarcinoma
NCT02526771CI-TRIAL-00021595unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to compare the surgical outcomes of conventional lymph node dissection with unconventional lymph node dissection during resection of Intrahepatic cholangiocarcinoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Intrahepatic Cholangiocarcinoma | Intrahepatic Cholangiocarcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| conventional lymph node dissection | Procedure | — | UNRESOLVED |
| unconventional lymph node dissection | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- conventional lymph node dissection
- description
- conventional lymph node dissection during resection of intrahepatic cholangiocarcinoma
- interventionNames
- Procedure: conventional lymph node dissection
- type
- ACTIVE_COMPARATOR
- label
- unconventional lymph node dissection
- description
- unconventional lymph node dissection during resection of intrahepatic cholangiocarcinoma
- interventionNames
- Procedure: unconventional lymph node dissection
Primary outcomes (1)
- measure
- overall survival
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Male or female patients \> 18 years and \<=70 years of age. * Diagnosis of intrahepatic cholangiocarcinoma ( through imaging, serology, intraoperative frozen, etc.) * No lymph node metastasis preoperatively or intraoperatively. * Tumors can be completely resected. * Criteria of liver function: Child A-B level, serum bilirubin ≤ 1.5 times the upper limit of normal value, alanine aminotransferase and aspartate aminotransferase ≤ 2 times the upper limit of normal value. * Patients who can understand this trial and have signed information consent. Exclusion Criteria:Lymph node metastasis preoperatively. * Tumors can not be resected . * Patients with apparent cardiac, pulmonary, cerebral and renal dysfunction, which may affect the treatment of Intrahepatic cholangiocarcinoma. * Patients with a medical history of other malignant tumors. * Subjects participating in other clinical trials. * liver function:Child C.
References
Publications (0)
Data not yet available
No reference posted for this study.